JP4808316B2 - 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン - Google Patents

多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン Download PDF

Info

Publication number
JP4808316B2
JP4808316B2 JP2000592015A JP2000592015A JP4808316B2 JP 4808316 B2 JP4808316 B2 JP 4808316B2 JP 2000592015 A JP2000592015 A JP 2000592015A JP 2000592015 A JP2000592015 A JP 2000592015A JP 4808316 B2 JP4808316 B2 JP 4808316B2
Authority
JP
Japan
Prior art keywords
growth hormone
cells
administered
csf
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000592015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002534393A (ja
JP2002534393A5 (https=
Inventor
ジャンニ，アレッサンドロ・マッシモ
Original Assignee
メルク・セローノ・ソシエテ・アノニム
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メルク・セローノ・ソシエテ・アノニム filed Critical メルク・セローノ・ソシエテ・アノニム
Publication of JP2002534393A publication Critical patent/JP2002534393A/ja
Publication of JP2002534393A5 publication Critical patent/JP2002534393A5/ja
Application granted granted Critical
Publication of JP4808316B2 publication Critical patent/JP4808316B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000592015A 1998-12-30 1999-12-30 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン Expired - Fee Related JP4808316B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
EP98124834.7 1998-12-30
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (3)

Publication Number Publication Date
JP2002534393A JP2002534393A (ja) 2002-10-15
JP2002534393A5 JP2002534393A5 (https=) 2010-11-18
JP4808316B2 true JP4808316B2 (ja) 2011-11-02

Family

ID=8233268

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000592015A Expired - Fee Related JP4808316B2 (ja) 1998-12-30 1999-12-30 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン

Country Status (15)

Country Link
US (1) US20060029581A1 (https=)
EP (3) EP1016413A1 (https=)
JP (1) JP4808316B2 (https=)
AT (1) ATE342064T1 (https=)
AU (2) AU772222B2 (https=)
BR (1) BR9916726A (https=)
CA (1) CA2354194A1 (https=)
CY (1) CY1107603T1 (https=)
DE (1) DE69933581T2 (https=)
DK (1) DK1140149T3 (https=)
ES (1) ES2275359T3 (https=)
IL (2) IL143994A0 (https=)
PT (1) PT1140149E (https=)
SI (1) SI1140149T1 (https=)
WO (1) WO2000040260A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
CA2417356A1 (en) 2000-08-01 2002-02-07 Yissum Research Development Company Directed differentiation of embryonic cells
ES2380009T3 (es) * 2001-07-31 2012-05-07 Genzyme Global S.A.R.L. Métodos para movilizar las células madre/progenitoras
CA2540529C (en) * 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス，インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
JPH07505527A (ja) * 1992-03-30 1995-06-22 シェリング・コーポレーション ヒト樹状細胞のインビトロ発生およびそれらの用途
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
WO1997003684A1 (en) * 1995-07-21 1997-02-06 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
JPH09506245A (ja) * 1993-10-06 1997-06-24 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド 幹細胞増殖因子
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JPH10206423A (ja) * 1996-11-20 1998-08-07 Toa Medical Electronics Co Ltd 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
DE69430059T2 (de) * 1993-06-15 2002-11-14 British Biotech Pharmaceuticals Ltd., Cowley Freisetzung und Mobilisierung hämatopoietischer Zellen
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DE69919969T2 (de) * 1998-12-17 2005-09-29 Applied Research Systems Ars Holding N.V. Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07505527A (ja) * 1992-03-30 1995-06-22 シェリング・コーポレーション ヒト樹状細胞のインビトロ発生およびそれらの用途
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
JPH09506245A (ja) * 1993-10-06 1997-06-24 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド 幹細胞増殖因子
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
WO1997003684A1 (en) * 1995-07-21 1997-02-06 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
WO1997026326A1 (en) * 1996-01-16 1997-07-24 Depuy Orthopaedics, Inc. Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
JPH10206423A (ja) * 1996-11-20 1998-08-07 Toa Medical Electronics Co Ltd 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法

Also Published As

Publication number Publication date
WO2000040260A1 (en) 2000-07-13
AU2103900A (en) 2000-07-24
JP2002534393A (ja) 2002-10-15
US20060029581A1 (en) 2006-02-09
IL143994A0 (en) 2002-04-21
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
EP1140149B1 (en) 2006-10-11
AU772222B2 (en) 2004-04-22
EP1779865A1 (en) 2007-05-02
ATE342064T1 (de) 2006-11-15
EP1016413A1 (en) 2000-07-05
SI1140149T1 (sl) 2007-02-28
DK1140149T3 (da) 2007-02-19
IL143994A (en) 2009-06-15
CY1107603T1 (el) 2013-03-13
AU2004203355A1 (en) 2004-08-19
DE69933581D1 (de) 2006-11-23
EP1140149A1 (en) 2001-10-10
BR9916726A (pt) 2001-09-11
CA2354194A1 (en) 2000-07-13
PT1140149E (pt) 2007-01-31
ES2275359T3 (es) 2007-06-01

Similar Documents

Publication Publication Date Title
ES2330193T3 (es) Hormona de crecimiento humano para estimular la movilizacion de celulas madre hematopoyeticas pluripotentes.
AU2001281800A1 (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
JP2005336202A (ja) マクロファージ炎症蛋白変種
US6447766B1 (en) Method of mobilizing hematopoietic stem cells
JP4808316B2 (ja) 多能性造血幹細胞の動員を刺激するためのヒト成長ホルモン
AU712235B2 (en) Method of mobilizing hematopoietic stem cells
US6348444B1 (en) Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
JPH08127539A (ja) ヒトｉｌ−１１を含有する末梢血幹細胞増加剤
EP1033997B1 (en) Method of mobilizing hematopoietic stem cells
MXPA01006681A (en) Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
CN1205708A (zh) 动员造血干细胞的方法
JPH07118163A (ja) β２−ミクログロブリンを含有する組成物
MXPA98003217A (en) Method of mobilization of hematopoyetic mother cells

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061109

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20071206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100318

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100611

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100921

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110512

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110707

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110728

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110817

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140826

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees